Abeona Therapeutics Appoints New Chief Medical Officer

Abeona Therapeutics (NASDAQ:ABEO) appointed Dr. Juan Ruiz as the company’s chief medical officer.
As quoted in the press release:

He will be responsible for leading all clinical development, medical affairs and related functions and will report directly to Timothy J. Miller, Ph.D., President and CEO.
Dr. Juan Ruiz is well regarded for his extensive research in molecular biology and gene therapy. He has previously held global leadership positions at Lykera Biomed and Digna Biotech, where he spent over 13 years leading teams dedicated to developing gene therapy translational medicine programs. During his tenure as Chief Medical Officer of Digna Biotech, Dr. Ruiz’s proven track record demonstrated a “start to finish” scope, from proof-of-concept studies and regulatory IND and IMPD submissions, to manufacturing, clinical trial design and execution, and partnering and licensing activities. In addition, he has expertise in the manufacturing and quality control of the adenoviral vectors that were tested in his clinical trials.

Click here to read the full press release.

Source: globenewswire.com